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An outbreak of cephalosporin-resistant Klebsiella pneumoniae occurred in a neonatal intensive care unit in
Sa˜o Paulo, Brazil. Of the 10 pulsotypes identified during the outbreak and follow-up periods, nine produced
CTX-M-2 or its new variant CTX-M-59 and one produced SHV-5. blaCTX-M-2/59 genes were located on closely
related plasmids that were transferable.
Klebsiella pneumoniae has long been known to cause out-
breaks of infections in neonatal intensive care units (NICUs).
Since the advent of extended-spectrum -lactamases (ESBLs),
many such outbreaks have been associated with ESBL-produc-
ing strains (7). Most outbreak investigations of ESBL-produc-
ing K. pneumoniae in NICUs have attributed the epidemics to
dissemination of single clones, whereas only a few studies re-
ported involvement of more than one strain in an outbreak
setting (2, 6). We here describe the molecular epidemiology of
a multiclonal outbreak in a Brazilian NICU caused by K. pneu-
moniae that produced CTX-M-type ESBLs including CTX-M-
59, a novel variant of CTX-M-2.
MATERIALS AND METHODS
Bacterial strains and plasmids. The outbreak occurred in the NICU of a
hospital near Sa˜o Paulo in October 2003. A total of 10 cephalosporin-resistant K.
pneumoniae strains were isolated at the time. Five were obtained from clinical
specimens (one each from blood, cerebrospinal fluid, catheter tip, urine, and
oropharynx), four from perirectal swabs, and one from a mother’s milk. Subse-
quently, 37 nonrepetitive, cephalosporin-resistant K. pneumoniae strains were
isolated from perirectal, axillary, and oropharyngeal swabs during a follow-up
investigation between May and August 2004. Additionally, two more strains were
identified from a catheter tip and blood culture during the follow-up period.
Thus, a total of 49 strains were included in the study.
Escherichia coli DH10B was used as the host for cloning experiments. Chlor-
amphenicol-resistant pBC-SK() plasmid (Stratagene, La Jolla, CA) was used as
the cloning vector. E. coli XL1-Blue Rifr NAr was used as the recipient for
conjugation and transformation experiments. Bacterial cultures were routinely
grown in Luria-Bertani (LB) broth at 37°C.
PFGE. Pulsed-field gel electrophoresis (PFGE) analysis was performed using
restriction enzyme XbaI (New England Biolabs, Ipswich, MA) and a CHEF III
DR electrophoresis system (Bio-Rad, Hercules, CA). Relatedness of the strains
was determined according to the criteria of Tenover et al. (9).
Susceptibility testing. MICs of cefotaxime with and without clavulanic acid,
ceftazidime with and without clavulanic acid, cefepime, aztreonam, ertapenem,
ciprofloxacin, and gentamicin were determined for all study strains by use of
Etest strips according to the instructions from the manufacturer (AB Biodisk,
Solna, Sweden). Production of ESBL was confirmed by the disk diffusion method
endorsed by the Clinical and Laboratory Standards Institute (CLSI) (3).
PCR analysis and sequencing. Primer sets to detect blaTEM (5), blaSHV (10),
and blaCTX-M (4) were used for PCR analysis to detect the ESBL genes in the
study strains. Nucleotide sequencing was performed with an ABI3100 genetic
analyzer. The full sequences of blaCTX-M genes were obtained using a set of
primers flanking the genes (Table 1).
PCR cloning of blaCTX-M-2/59. To assess whether the amino acid substitution
observed with CTX-M-59 affected the level of resistance to -lactams, E. coli
clones producing either CTX-M-2 or CTX-M-59 were constructed. The struc-
tural genes corresponding to the enzymes were amplified with primers
CTXM2F-XbaI and CTXM2R-BamHI (Table 1). The PCR product was di-
gested with XbaI and BamHI (New England Biolabs) and ligated with pBC-
SK(). E. coli DH10B was then transformed by these recombinant plasmids by
electroporation. Transformants were selected on LB agar plates containing 50
g/ml of ampicillin and 30 g/ml of chloramphenicol. After confirmation of the
nucleotide sequences, E. coli DH10B(pCTX-M-2) producing CTX-M-2 and E.
coli DH10B(pCTX-M-59) producing CTX-M-59 were used to determine the
MICs of -lactams.
Conjugation and transformation. The standard broth mating method was
employed for conjugation experiments (10). Transconjugants were selected on
LB agar plates containing 50 g/ml of ampicillin, 50 g/ml of rifampin, and 50
g/ml of nalidixic acid. For the strains that did not yield transconjugants, the
plasmids were extracted by the modified alkaline lysis method described previ-
ously (8). E. coli XL1-Blue Rifr NAr was transformed with the plasmids by
electroporation. Transformants were selected on LB agar plates containing 50
g/ml of ampicillin.
DNA hybridization. Plasmids were extracted from the transconjugants and
transformants by the modified alkaline lysis method (8) and digested with EcoRI,
HindIII, or PstI (New England Biolabs). The plasmids were then subjected to
electrophoresis in an 0.8% agarose gel. The plasmids digested with PstI were
hybridized with a digoxigenin-labeled DNA probe specific for blaCTX-M-2/59 using
the PCR DIG detection system (Roche Diagnostics, Indianapolis, IN).
Nucleotide sequence accession numbers. The nucleotide sequences of blaCTX-M-59
and blaSHV-85 have been deposited in the GenBank/EMBL/DDBJ database under
accession no. DQ408762 and DQ322460, respectively.
RESULTS AND DISCUSSION
PFGE. PFGE revealed the presence of 10 pulsotypes (Table
2; Fig. 1). Pulsotypes A and J were detected solely during the
outbreak and were possibly related to each other, while pul-
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sotype B was present both during and after the outbreak.
Pulsotypes C and D were commonly recovered during the
follow-up period. Taken together, these five pulsotypes ac-
counted for 82% of the study strains.
Susceptibilities of the study strains. All of the study strains
were confirmed as ESBL producers by the disk diffusion
method. Strains belonging to all pulsotypes except D had me-
dian cefotaxime MICs of greater than 256 g/ml. Strains with
pulsotype D had a median ceftazidime MIC of 256 g/ml but
a lower median cefotaxime MIC (48 g/ml). All strains were
susceptible to ertapenem and ciprofloxacin. They were variably
resistant to gentamicin.
PCR analysis and sequencing of -lactamase genes. All
PFGE pulsotypes except D gave amplicons consistent with
blaCTX-M. The sequences corresponded to CTX-M-2 for pul-
sotypes A, B, F, H, I, and J and CTX-M-59 for pulsotypes C,
E, and G (Table 2). CTX-M-59 is a novel variant of CTX-M-2
with an H89L substitution according to the Ambler numbering
scheme (1). Pulsotype D carried blaSHV, which was confirmed
to encode SHV-5 upon sequencing of the full open reading
frame. All the other pulsotypes except F were also positive for
blaSHV, which encoded various non-ESBL SHV enzymes in-
cluding SHV-1, -11, -77, and -85. SHV-85 is a novel variant of
SHV-11 with an L19M substitution, which is located within the
signal peptide. All pulsotypes except D were positive for bla-
TEM. The deduced amino acid sequences were consistent with
that of TEM-1.
Phenotype conferred by CTX-M-59. The -lactam MICs of
E. coli DH10B(pCTX-M-59) did not differ significantly from
those of E. coli DH10B(pCTX-M-2) (Table 3). Both clones
displayed susceptibility patterns typical for organisms produc-
ing CTX-M-type enzymes, with higher levels of resistance to
cefotaxime than to ceftazidime. These results suggested that
the kinetic properties of CTX-M-59 were not likely altered by
the H89L substitution compared with its progenitor CTX-M-2.
TABLE 1. Primers used for the study
Gene Primername Primer sequence
Product
size
(bp)
Reference
blaSHV SHV-F-S1 5-ATTTGTCGCTTCTTT
ACTCGC-3
1,051 10
SHV-R-S2 5-TTTATGGCGTTACCT
TTGACC-3
blaTEM TEM-F 5-ATGAGTATTCAACAT
TTCCGTG-3
840 5
TEM-R 5-TTACCAATGCTTAAT
CAGTGAG-3
blaCTX-M CTX-M/F 5-TTTGCGATGTGCAGT
ACCAGTAA-3
544 4
CTX-M/R 5-CGATATCGTTGGTG
GTGCCATA-3
blaCTX-M-2 CTXM2F 5-AAATGTGCTGCTCCT
TTCGTGAGC-3
1,122 This study
CTXM2R 5-AGGGTTCGTTGCAA
GACAAGACTG-3
CTXM2F
XbaIa
5-CGTCTAGAATGATG
ACTCAGAGCA-3
892 This study
CTXM2R
BamHIa
5-CGGGATCCTCAGAA
ACCGTGGGTT-3
a Restriction sites are underlined in the sequences.
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Mating experiments. Transconjugants were obtained from
representative strains of all pulsotypes at frequencies of 2 
105 or higher per recipient cell except for pulsotypes A and J,
for which no transconjugant was obtained. All transconjugants
except for that from pulsotype D were resistant to cefotaxime
but not ceftazidime. PCR analysis for these transconjugants
yielded amplicons with primers specific for blaCTX-M-2 and
blaTEM, indicating successful transfer of blaCTX-M-2/59 and blaTEM-1.
The transconjugant from pulsotype D was resistant to ceftazi-
dime but not cefotaxime and was positive for blaSHV by PCR
analysis, indicating conjugal transfer of blaSHV-5. The plasmids
harboring blaCTX-M-2 in representative strains from profiles A
and J were successfully transferred to the recipient strain by
transformation, which was confirmed by PCR analysis likewise.
The MICs for the transconjugants and transformants are
shown in Table 4.
Plasmid analysis and DNA hybridization. Plasmids obtained
from the transconjugants and transformants encoding blaCTX-M-2/59
shared identical or very similar banding patterns with any of
the three restriction enzymes, whereas that from the transcon-
jugant encoding blaSHV-5 was distinct (results not shown). The
sizes of these plasmids were estimated to be ca. 50 kb. The
probe for blaCTX-M-2/59 hybridized with two bands with similar
sizes, ca. 1.5 kb and 0.5 kb, for the plasmids from all pulsotypes
except D (Fig. 2). Two bands were generated because blaCTX-M-2/59
contains a PstI restriction site. This finding suggested that the
FIG. 1. PFGE profiles of the 10 pulsotypes identified in the study.
M, marker.
TABLE 3. MICs of E. coli DH10B with recombinant plasmids
encoding blaCTX-M-2/59
E. coli strain
MIC (g/ml) of druga:
CAZ CAZ/CLA CTX
CTX/
CLA ATM FEP ERT
DH10B(pCTX-M-2) 8 0.38 128 0.094 12 4 0.016
DH10B(pCTX-M-59) 8 0.38 96 0.094 12 4 0.016
a Abbreviations: CAZ, ceftazidime; CAZ/CLA, ceftazidime plus clavulanic
acid; CTX, cefotaxime; CTX/CLA, cefotaxime plus clavulanic acid; ATM,
aztreonam; FEP, cefepime; ERT, ertapenem.
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genetic support of blaCTX-M-2/59 in this outbreak was likely
uniform regardless of pulsotypes. Taken together, the out-
break phase was initiated by three genomic clones carrying
similar plasmids, all encoding blaCTX-M-2. It appears that one
of the plasmids then further disseminated to other clones and
produced a variant plasmid encoding blaCTX-M-59. Thus, we
speculate that these ESBL-encoding plasmids persisted,
evolved, and disseminated among different clones of K. pneu-
moniae in the confined environment of a NICU over the 10-
month period.
Conclusion. We described a multiclonal outbreak of K.
pneumoniae producing CTX-M-2 and its variant CTX-M-59
ESBLs which took place in a Brazilian NICU. In addition to
the spread of each clonal group, dissemination of identical or
related plasmids harboring the CTX-M-type ESBL genes
among different clonal groups was responsible for the persis-
tence of ESBL-producing K. pneumoniae over time.
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